Aurobindo Pharma Announcements
Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
05 Feb, 2026 | 12:35pm • Source: NSE
Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
05 Feb, 2026 | 12:30pm • Source: NSE
Intimation of participation in Axis Capital''s India Investor Conference to be held on February 12, 2026.
05 Feb, 2026 | 12:02pm • Source: BSE
Intimation of participation in Nuvama's India Investor Conference to be held on February 11, 2026.
05 Feb, 2026 | 12:00pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about Schedule of meet
02 Feb, 2026 | 11:08am • Source: NSE
Intimation of date of earning call on the Unaudited Financial Results for the third quarter and nine months period ended December 31, 2025.
02 Feb, 2026 | 10:27am • Source: BSE
Submission of clarification on significant volume movement in Company''s shares.
02 Feb, 2026 | 10:07am • Source: BSE
The Exchange has sought clarification from Aurobindo Pharma Ltd on February 01, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
01 Feb, 2026 | 12:37pm • Source: BSE
Submission of clarification on significant volume movement in Company''s shares sought vide letter No.NSE/CM/Surveilance/16398 dated January 30, 2026.
31 Jan, 2026 | 11:16am • Source: BSE
Aurobindo Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and...
30 Jan, 2026 | 04:43pm • Source: BSE
Intimation of incorporation of new step-down Subsidiary in Philippines.
23 Jan, 2026 | 05:09pm • Source: BSE
Intimation of receipt of Notice of Compliance from Health Canada by Curateq Biologics Private Limited, a wholly owned subsidiary of the Company for its biosimilar...
09 Jan, 2026 | 03:19pm • Source: BSE
Intimation of plant visit by investors.
08 Jan, 2026 | 05:16pm • Source: BSE
Submission of certificate under Regulation 74(5) of SEBI (DP Regulations, 2018 for the quarter ended 31.12.2025.
05 Jan, 2026 | 12:20pm • Source: BSE
Intimation of the acquisition of the branded non-oncology prescription formulations business of Khandelwal Laboratories Private Limited by Auro Pharma Limited, a wholly...
01 Jan, 2026 | 06:05pm • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about update on acquisition of 26% stake in Swarnaakshu Solar Power Private Limited.
30 Dec, 2025 | 11:54am • Source: NSE
Update on acquisition of 26% Stake in Swarnaakshu Solar Power Private Limited.
30 Dec, 2025 | 11:15am • Source: BSE
This is to inform that Curateq Biologics Private Limited a wholly owned subsidiary of the Company has mutually agreed to terminate its agreement with BioFactura...
27 Dec, 2025 | 11:54am • Source: BSE
Intimation of closure of trading window
24 Dec, 2025 | 11:59am • Source: BSE
Aurobindo Pharma Limited has informed the Exchange about acquisition of additional 20% stake in Luoxin Aurovitas Pharma (Chengdu) Co. Ltd, China, a joint venture company
23 Dec, 2025 | 02:06pm • Source: NSE